Literature DB >> 25945008

Biliary drainage strategy of unresectable malignant hilar strictures by computed tomography volumetry.

Ei Takahashi1, Mitsuharu Fukasawa1, Tadashi Sato1, Shinichi Takano1, Makoto Kadokura1, Hiroko Shindo1, Yudai Yokota1, Nobuyuki Enomoto1.   

Abstract

AIM: To identify criteria for predicting successful drainage of unresectable malignant hilar biliary strictures (UMHBS) because no ideal strategy currently exists.
METHODS: We examined 78 patients with UMHBS who underwent biliary drainage. Drainage was considered effective when the serum bilirubin level decreased by ≥ 50% from the value before stent placement within 2 wk after drainage, without additional intervention. Complications that occurred within 7 d after stent placement were considered as early complications. Before drainage, the liver volume of each section (lateral and medial sections of the left liver and anterior and posterior sections of the right liver) was measured using computed tomography (CT) volumetry. Drained liver volume was calculated based on the volume of each liver section and the type of bile duct stricture (according to the Bismuth classification). Tumor volume, which was calculated by using CT volumetry, was excluded from the volume of each section. Receiver operating characteristic (ROC) analysis was performed to identify the optimal cutoff values for drained liver volume. In addition, factors associated with the effectiveness of drainage and early complications were evaluated.
RESULTS: Multivariate analysis showed that drained liver volume [odds ratio (OR) = 2.92, 95%CI: 1.648-5.197; P < 0.001] and impaired liver function (with decompensated liver cirrhosis) (OR = 0.06, 95%CI: 0.009-0.426; P = 0.005) were independent factors contributing to the effectiveness of drainage. ROC analysis for effective drainage showed cutoff values of 33% of liver volume for patients with preserved liver function (with normal liver or compensated liver cirrhosis) and 50% for patients with impaired liver function (with decompensated liver cirrhosis). The sensitivity and specificity of these cutoff values were 82% and 80% for preserved liver function, and 100% and 67% for impaired liver function, respectively. Among patients who met these criteria, the rate of effective drainage among those with preserved liver function and impaired liver function was 90% and 80%, respectively. The rates of effective drainage in both groups were significantly higher than in those who did not fulfill these criteria (P < 0.001 and P = 0.02, respectively). Drainage-associated cholangitis occurred in 9 patients (12%). A smaller drained liver volume was associated with drainage-associated cholangitis (P < 0.01).
CONCLUSION: Liver volume drainage ≥ 33% in patients with preserved liver function and ≥ 50% in patients with impaired liver function correlates with effective biliary drainage in UMHBS.

Entities:  

Keywords:  Biliary drainage; Cholangiocarcinoma; Cholangitis; Computed tomography volumetry; Hilar biliary stricture; Liver function

Mesh:

Substances:

Year:  2015        PMID: 25945008      PMCID: PMC4408467          DOI: 10.3748/wjg.v21.i16.4946

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.

Authors:  Martin L Freeman; Carol Overby
Journal:  Gastrointest Endosc       Date:  2003-07       Impact factor: 9.427

2.  Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study.

Authors:  G D De Palma; G Galloro; S Siciliano; P Iovino; C Catanzano
Journal:  Gastrointest Endosc       Date:  2001-05       Impact factor: 9.427

3.  Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction.

Authors:  Itaru Naitoh; Hirotaka Ohara; Takahiro Nakazawa; Tomoaki Ando; Kazuki Hayashi; Fumihiro Okumura; Yasutaka Okayama; Hitoshi Sano; Yasuhiro Kitajima; Masaaki Hirai; Tessin Ban; Katsuyuki Miyabe; Koichiro Ueno; Hiroaki Yamashita; Takashi Joh
Journal:  J Gastroenterol Hepatol       Date:  2009-02-12       Impact factor: 4.029

4.  Unilateral versus bilateral drainage using self-expandable metallic stent for unresectable hilar biliary obstruction.

Authors:  Hirotoshi Iwano; Shomei Ryozawa; Noriko Ishigaki; Kumiko Taba; Manabu Senyo; Kanako Yoshida; Isao Sakaida
Journal:  Dig Endosc       Date:  2010-11-30       Impact factor: 7.559

5.  Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment.

Authors:  Ariane Vienne; Ehlam Hobeika; Hervé Gouya; Nathanael Lapidus; Jacques Fritsch; André Daniel Choury; Ariane Chryssostalis; Marianne Gaudric; Gilles Pelletier; Catherine Buffet; Stanislas Chaussade; Frédéric Prat
Journal:  Gastrointest Endosc       Date:  2010-10       Impact factor: 9.427

6.  Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study.

Authors:  Giovanni D De Palma; Angelo Pezzullo; Maria Rega; Marcello Persico; Francesco Patrone; Luigi Mastantuono; Giovanni Persico
Journal:  Gastrointest Endosc       Date:  2003-07       Impact factor: 9.427

7.  Result of endoscopic biliary drainage in hilar cholangiocarcinoma.

Authors:  Rungsun Rerknimitr; Nusont Kladcharoen; Varocha Mahachai; Pinit Kullavanijaya
Journal:  J Clin Gastroenterol       Date:  2004-07       Impact factor: 3.062

8.  Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents.

Authors:  John L S Cheng; Marco J Bruno; Jacques J Bergman; Erik A Rauws; Guido N Tytgat; Kees Huibregtse
Journal:  Gastrointest Endosc       Date:  2002-07       Impact factor: 9.427

9.  Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study.

Authors:  David G Perdue; Martin L Freeman; James A DiSario; Douglas B Nelson; M Brian Fennerty; John G Lee; Carol S Overby; Michael E Ryan; Gary S Bochna; Harry W Snady; Joseph P Moore
Journal:  J Clin Gastroenterol       Date:  2008-10       Impact factor: 3.062

10.  Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.

Authors:  Woo Hyun Paik; Young Soo Park; Jin-Hyeok Hwang; Sang Hyub Lee; Chang Jin Yoon; Sung-Gwon Kang; Jae Kyung Lee; Ji Kon Ryu; Yong-Tae Kim; Yong Bum Yoon
Journal:  Gastrointest Endosc       Date:  2008-07-26       Impact factor: 9.427

View more
  14 in total

1.  Peripheral portal vein-oriented non-dilated bile duct puncture for percutaneous transhepatic biliary drainage.

Authors:  Hiroaki Shimizu; Atsushi Kato; Tsukasa Takayashiki; Satoshi Kuboki; Masayuki Ohtsuka; Hideyuki Yoshitomi; Katsunori Furukawa; Masaru Miyazaki
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

2.  A preliminary single-center investigation of percutaneous biliary stenting in malignant hilar biliary obstruction: what impacts the clinical success and the long-term outcomes?

Authors:  Xiaonan Mao; Feng Wen; Hongyuan Liang; Wei Sun; Zaiming Lu
Journal:  Support Care Cancer       Date:  2021-05-14       Impact factor: 3.603

Review 3.  Endoscopic biliary stenting for unresectable malignant hilar obstruction.

Authors:  Mitsuharu Fukasawa; Shinichi Takano; Hiroko Shindo; Ei Takahashi; Tadashi Sato; Nobuyuki Enomoto
Journal:  Clin J Gastroenterol       Date:  2017-10-19

4.  Can we insert a covered stent, partially or not, in case of hilar biliary stenosis?

Authors:  Guido Costamagna; Andrea Tringali
Journal:  Endosc Int Open       Date:  2017-11-22

5.  Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma.

Authors:  Tianyi Fang; Hao Wang; Yunfu Cui; Zhidong Wang; Yufu Wang; Xuan Lin
Journal:  Dis Markers       Date:  2019-02-04       Impact factor: 3.464

Review 6.  Personalized Endoscopy in Complex Malignant Hilar Biliary Strictures.

Authors:  Ivo Boškoski; Tommaso Schepis; Andrea Tringali; Pietro Familiari; Vincenzo Bove; Fabia Attili; Rosario Landi; Vincenzo Perri; Guido Costamagna
Journal:  J Pers Med       Date:  2021-01-29

7.  Hilar Malignant Biliary Obstruction Treated with Four Metallic Stents Involving a New Slim Device.

Authors:  Yuki Noguchi; Mitsuru Sugimoto; Yuichiro Kiko; Tadayuki Takagi; Rei Suzuki; Naoki Konno; Hiroyuki Asama; Yuki Sato; Hiroki Irie; Jun Nakamura; Mika Takasumi; Minami Hashimoto; Tsunetaka Kato; Ryoichiro Kobashi; Yuko Hashimoto; Takuto Hikichi; Hiromasa Ohira
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

Review 8.  Recent advances regarding endoscopic biliary drainage for unresectable malignant hilar biliary obstruction.

Authors:  Hironari Kato; Kazuyuki Matsumoto; Hiroyuki Okada
Journal:  DEN open       Date:  2021-09-07

9.  Risk factors of ineffective drainage in uncovered self-expandable metal stenting for unresectable malignant hilar biliary strictures.

Authors:  Koji Takahashi; Toshio Tsuyuguchi; Atsushi Saiga; Takuro Horikoshi; Yoshihiko Ooka; Harutoshi Sugiyama; Masato Nakamura; Junichiro Kumagai; Mutsumi Yamato; Yotaro Iino; Ayako Shingyoji; Hiroshi Ohyama; Shin Yasui; Rintaro Mikata; Yuji Sakai; Naoya Kato
Journal:  Oncotarget       Date:  2018-06-15

Review 10.  Endoscopic Stenting in Hilar Cholangiocarcinoma: When, How, and How Much to Drain?

Authors:  Andrea Tringali; Ivo Boškoski; Guido Costamagna
Journal:  Gastroenterol Res Pract       Date:  2019-11-04       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.